Tolylboronic acid → 3-(2,4-difluorophenyl)-6-{3-[4-(methylsulfonyl)piperazin-1-yl]propoxy}-2-p-tolyl-1H-inden-1-one
Reaction equation
Br[C:2]1[C:3](=[O:33])[C:4]2[C:9]([C:10]=1[C:11]1[CH:16]=[CH:15][C:14]([F:17])=[CH:13][C:12]=1[F:18])=[CH:8][CH:7]=[C:6]([O:19][CH2:20][CH2:21][CH2:22][N:23]1[CH2:28][CH2:27][N:26]([S:29]([CH3:32])(=[O:31])=[O:30])[CH2:25][CH2:24]1)[CH:5]=2.O1CCN(CCO[C:43]2[CH:51]=[C:50]3[C:46]([C:47](C4C=CC=CC=4)=C(Br)C3=O)=[CH:45][CH:44]=2)CC1.B(O)(O)C1C=CC(C)=CC=1>>[F:18][C:12]1[CH:13]=[C:14]([F:17])[CH:15]=[CH:16][C:11]=1[C:10]1[C:9]2[C:4](=[CH:5][C:6]([O:19][CH2:20][CH2:21][CH2:22][N:23]3[CH2:28][CH2:27][N:26]([S:29]([CH3:32])(=[O:30])=[O:31])[CH2:25][CH2:24]3)=[CH:7][CH:8]=2)[C:3](=[O:33])[C:2]=1[C:43]1[CH:51]=[CH:50][C:46]([CH3:47])=[CH:45][CH:44]=1Participants
4
Procedure
The procedure of Step 7 of Example 1 was repeated except for using 2-bromo-3-(2,4-difluorophenyl)-6-[3-(4-(methylsulfonyl)piperazin-1-yl)propoxy]-1H-inden-1-one obtained in Step 1 as a starting material instead of 6-(2-morpholinoethoxy)-2-bromo-3-phenyl-1H-inden-1-one and p-tolylboronic acid instead of 3-pyridinylboronic acid to obtain the title compound (76%).
Sources & evidence
- ORD record
- ord-973ab7a378f94c01bb2405c08d839d01
- Source dataset
- uspto-grants-2014_11
- Patent number
- US08877747B2
Reaction notes
Loading…